Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Identification of Hospitalized Patients at High-risk for Clinical Deterioration During the First 72-hours in an Internal Medicine Department. A Prospective, Continuous, Physiologic Big-data-analysis Study

NCT04220359 is registered in ClinicalTrials.gov with Biobeat Technologies Ltd. as lead sponsor.

NCT NCT04220359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04220359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Identification of Hospitalized Patients at High-risk for Clinical Deterioration During the First 72-hours in an Internal Medicine Department. A Prospective, Continuous, Physiologic Big-data-analysis Study
Lead sponsor
Biobeat Technologies Ltd.
Phase
Observational
Overall status
Completed
Start date
July 6, 2020
Completion date
April 30, 2021
Enrollment
410 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical deterioration, hemodynamic instability